TP53 and colorectal carcinoma: Notably, thyroid cancer tissue stained with antibodies also used for CRCs extended our previous findings (Jun et al., 2021), underscoring that SQLE reduction, GSK3β inhibition, and p53 degradation due to aging and increased CRC malignancy are specific events in gastrointestinal cancers (Figure S3).